Krystal Biotech, Inc. (NASDAQ:KRYS) Receives $190.22 Average Target Price from Analysts

Krystal Biotech, Inc. (NASDAQ:KRYS – Get Free Report) has earned an average rating of “Moderate Buy” from the ten research firms that are presently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a hold recommendation and nine have given a buy recommendation to the company. The average 1-year price […]